08:06 EDT Cabaletta Bio files automatic mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CABA:
- Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Cabaletta Bio Receives Orphan Drug Status for CABA-201
- Cabaletta Bio granted Orphan Drug designation to CABA-201
- Cabaletta Bio treatment of systemic sclerosis granted orphan designation
- Cabaletta Bio, Inc. (CABA) Q4 Earnings Cheat Sheet